Literature DB >> 16989737

Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.

Sarah E Gray1, Elaine Kay, Mary Leader, M Mabruk.   

Abstract

Deletions of the short arm of chromosome 9 have been reported in different types of malignancies. This chromosomal region contains a number of known tumour suppressor genes, including the p16INK4A (CDKN2A), p15INK4B and MTAP tumour suppressor genes located at 9p21. In this study twenty-two paraffin embedded invasive cutaneous SCC were examined for allelic imbalance/ loss of heterozygosity (AI/LOH) of the 9p region (in particular 9p21), and for p16 protein expression. DNA was isolated from microdissected sections of normal and tumour cells and analysed for AI/LOH by using six fluorescently labelled microsatellite markers that map to the 9p region. P16 protein expression was examined by immunohistochemistry. At each of the six microsatellite markers the majority of SCC analysed showed AI/LOH. Overall both AI/LOH within the CDKN2A locus and absence of p16 protein expression were frequent among the cutaneous SCC analysed, suggesting that p16 inactivation may play a role in cutaneous SCC development. The majority of the SCC analysed also had AI/LOH of the marker within the MTAP gene, and at markers flanking the CDKN2A gene; thus further investigation as to a possible role for these genes in the development of cutaneous SCC is warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16989737      PMCID: PMC3933159          DOI: 10.1111/j.1582-4934.2006.tb00437.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  50 in total

1.  Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor.

Authors:  L Mortier; P Marchetti; E Delaporte; E Martin de Lassalle; P Thomas; F Piette; P Formstecher; R Polakowska; P-M Danzé
Journal:  Cancer Lett       Date:  2002-02-25       Impact factor: 8.679

2.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

3.  Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors.

Authors:  Y Ichikawa; S Yoshida; Y Koyama; M Hirai; T Ishikawa; M Nishida; H Tsunoda; T Kubo; M Miwa; K Uchida
Journal:  Int J Cancer       Date:  1996-12-20       Impact factor: 7.396

4.  p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx.

Authors:  P Jares; P L Fernández; A Nadal; M Cazorla; L Hernández; M Pinyol; S Hernández; J Traserra; A Cardesa; E Campo
Journal:  Oncogene       Date:  1997-09-18       Impact factor: 9.867

5.  Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.

Authors:  José M García-Castellano; Alberto Villanueva; John H Healey; Rebecca Sowers; Carlos Cordon-Cardo; Andrew Huvos; Joseph R Bertino; Paul Meyers; Richard Gorlick
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

6.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

7.  Methylthioadenosine phosphorylase regulates ornithine decarboxylase by production of downstream metabolites.

Authors:  Ahmad L Subhi; Paula Diegelman; Carl W Porter; Baiqing Tang; Zichun J Lu; George D Markham; Warren D Kruger
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

8.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.

Authors:  D E Quelle; F Zindy; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

9.  Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.

Authors:  Iris Behrmann; Susanne Wallner; Waraporn Komyod; Peter C Heinrich; Marion Schuierer; Reinhard Buettner; Anja-Katrin Bosserhoff
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Growth suppression by p16ink4 requires functional retinoblastoma protein.

Authors:  R H Medema; R E Herrera; F Lam; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

View more
  4 in total

1.  Molecular markers in cutaneous squamous cell carcinoma.

Authors:  Anthony P Tufaro; Jim C-M Chuang; Nijaguna Prasad; Alice Chuang; Tony C Chuang; Anne C Fischer
Journal:  Int J Surg Oncol       Date:  2011-08-09

2.  Exploring Potential Biomarkers, Ferroptosis Mechanisms, and Therapeutic Targets Associated with Cutaneous Squamous Cell Carcinoma via Integrated Transcriptomic Analysis.

Authors:  Wenxing Su; Biao Huang; Qingyi Zhang; Wei Han; Lu An; Yi Guan; Jiang Ji; Daojiang Yu
Journal:  J Healthc Eng       Date:  2022-09-19       Impact factor: 3.822

3.  Blocking endogenous peroxidases: a cautionary note for immunohistochemistry.

Authors:  Razvan Tudor Radulescu; Thomas Boenisch
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

4.  Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection.

Authors:  Ismail El-Mokadem; Alison Lim; Thomas Kidd; Katherine Garret; Norman Pratt; David Batty; Stewart Fleming; Ghulam Nabi
Journal:  BMC Cancer       Date:  2016-07-27       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.